Business
Covalon Attracts Well-Known Medical Industry Sales Executive
Covalon Attracts Well-Known Medical Industry Sales Executive Canada NewsWire ...
About this update from Covalon Technologies Ltd.
[{"type":"text","content":"\n \n \n \n Covalon Attracts Well-Known Medical Industry Sales Executive\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n MISSISSAUGA, ON\n \n \n ,\n \n \n May 19, 2022\n \n \n /CNW/ - Covalon Technologies Ltd. (the \"Company\" or \"Covalon\") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced that\n \n Mark Doolittle\n \n has joined the Company as Senior Vice President, Commercial Sales.\n \n \n \n \n \n \n \n \n \n \"I am delighted to welcome Mark to Covalon,\" said\n \n Brian Pedlar\n \n , Chief Executive Officer of Covalon. \"We are continuing to build a transformative leadership team and his years of experience in commercial leadership will help our Company as we grow our US and international business. Mark's creativity, passion, and expertise will be an asset to us as we expand the adoption of our infection prevention and biological collagen solutions.\"\n \n \n Mr. Doolittle brings over 20 years of medical and B2B sales and marketing experience to Covalon. He has substantial leadership experience managing high-performing teams and managing partnerships both domestically and internationally.  Prior to joining Covalon, Mr. Doolittle spent the last 12 years at US-based Cantel Medical, the global leader in infection prevention in GI Endoscopy. In his most recent role, he served as the Vice President of US Commercial. During his tenure, Cantel recorded record profits, becoming a\n \n $1B\n \n organization, including the medical division growing from\n \n $30M\n \n to\n \n $350M\n \n . In 2021, Cantel was acquired for\n \n $3.6B\n \n .\n \n \n Throughout his career, Mr. Doolittle has held multiple progressive roles including Vice President of Corporate Accounts, where he gained extensive knowledge of US healthcare Group Purchasing Organizations (\"GPOs\") and Integrated Delivery Networks (\"IDNs\"), and Vice President of Innovative Solutions, where he focused on technology innovations in healthcare. Mr. Doolittle holds a Bachelor's Degree from Gonzaga University.\n \n \n \n About...